Volatile organic compounds of biofluids for detecting lung cancer by an electronic nose based on artificial neural network
| Autor: | Mohamed I. Badawi, Taher S. Abdel-Mohdy, Marwa A Mohamed, Samir M. Abdel-Mageed, Samy H. Darwish, Ehab I. Mohamed |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Health Toxicology and Mutagenesis Biomedical Engineering Urine Gastroenterology General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Artificial Intelligence Internal medicine medicine Biological fluids Basal cell General Pharmacology Toxicology and Pharmaceutics Lung cancer General Immunology and Microbiology Electronic nose business.industry General Neuroscience General Medicine medicine.disease 030205 complementary & alternative medicine 030220 oncology & carcinogenesis Adenocarcinoma General Agricultural and Biological Sciences business Tissue biopsy |
| Zdroj: | Journal of Applied Biomedicine. 17:67-67 |
| ISSN: | 1214-0287 1214-021X |
| DOI: | 10.32725/jab.2018.006 |
| Popis: | Lung cancer (LC) incidence represents 11.5% of all new cancers, resulting in 1.72 million deaths worldwide in 2015. With the aim to investigate the capability of the electronic nose (e-nose) technology for detecting and differentiating complex mixtures of volatile organic compounds in biofluids ex-vivo, we enrolled 50 patients with suspected LC and 50 matching controls. Tissue biopsy was taken from suspicious lung mass for histopathological evaluation and blood, exhaled breath, and urine samples were collected from all participants and qualitatively processed using e-nose. Odor-print patterns were further analysed using the principal component analysis (PCA) and artificial neural network (ANN) analysis. Adenocarcinoma, non-small cell LC and squamous cell carcinoma were the predominant pathological types among LC patients. PCA cluster-plots showed a clear distinction between LC patients and controls for all biological samples; where the overall success ratios of classification for principal components #1 and #2 were: 95.46, 82.01, and 91.66% for blood, breath and urine samples, respectively. Moreover, ANN showed a better discrimination between LC patients and controls with success ratios of 95.74, 91.67 and 100% for blood, breath and urine samples, respectively. The e-nose is an easy noninvasive tool, capable of identifying LC patients from controls with great precision. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|